• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on the role of M2 type-activated macrophage in the progression of chronic kidney diseases (CKD).

Research Project

Project/Area Number 25461618
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Pediatrics
Research InstitutionNiigata University

Principal Investigator

Ikezumi Yohei  新潟大学, 医歯学総合病院, 講師 (70361897)

Co-Investigator(Kenkyū-buntansha) Kawachi Hiroshi  新潟大学, 医歯学系, 教授 (60242400)
Suzuki Toshiaki  新潟大学, 医歯学総合病院, 助教 (50419305)
Co-Investigator(Renkei-kenkyūsha) Narita Ichiei  新潟大学, 医歯学系, 教授 (20272817)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
KeywordsM2型活性化マクロファージ / 慢性腎臓病 / 尿細管間質線維化 / 糸球体硬化 / ステロイド抵抗性ネフローゼ症候群 / 酸化LDL / 線維化 / M2型活性化マクロファージ / 酸化LDL / ステロイド / ネフローゼ症候群
Outline of Final Research Achievements

The role of alternatively activated macrophages (M2) in progression of chronic kidney disease was examined by immunohistological staining of biopsy specimen and in vitro studies using human monocyte-derived macrophage.
We found that M2 exerted an anti-inflammatory effect at the site of inflamed-tissue, while playing a role in the progression of chronic lesions. In addition, we found that steroid, a widely used drug in the treatment of kidney diseases, could augment the chronic lesion. Combined treatment with antimetabolite could counteract the steroid-induced M2 activation, and might be useful for the treatment of CKD.

Report

(4 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report
  • 2013 Research-status Report
  • Research Products

    (19 results)

All 2016 2015 2014 2013 Other

All Journal Article (5 results) (of which Peer Reviewed: 5 results,  Acknowledgement Compliant: 3 results) Presentation (9 results) (of which Int'l Joint Research: 1 results,  Invited: 3 results) Book (5 results)

  • [Journal Article] Local leukocyte proliferation as a target for cyclophosphamide in the treatment of Henoch-Schönlein purpura nephritis grade VI.2016

    • Author(s)
      Kaneko M, Ikezumi Y, Yamada T, Hasegawa H, Kaneko U, Saitoh A.
    • Journal Title

      Nephrology (Carlton)

      Volume: 21 Issue: 1 Pages: 68-71

    • DOI

      10.1111/nep.12558

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.2016

    • Author(s)
      Takahashi Y, Ikezumi Y, Saitoh A.
    • Journal Title

      Nephrology (Carlton)

      Volume: in press Issue: 1 Pages: 49-57

    • DOI

      10.1111/nep.12737

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury.2015

    • Author(s)
      Ikezumi Y, Suzuki T, Yamada T, et al.
    • Journal Title

      Pediatric Nephrology

      Volume: 30 Issue: 6 Pages: 1007-1017

    • DOI

      10.1007/s00467-014-3023-0

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Glomerular epithelial cell phenotype in diffuse mesangial sclerosis: A report of two cases with markedly increased urinary podocyte excretion.2014

    • Author(s)
      Ikezumi Y, Suzuki T, Karasawa T
    • Journal Title

      Human Pathology

      Volume: 45 Issue: 8 Pages: 1778-1783

    • DOI

      10.1016/j.humpath.2014.03.017

    • Related Report
      2014 Research-status Report
    • Peer Reviewed
  • [Journal Article] Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis2013

    • Author(s)
      Ikezumi Y, Suzuki T, Karasawa T, et al
    • Journal Title

      American Journal of Nephrology

      Volume: 38 Issue: 2 Pages: 149-157

    • DOI

      10.1159/000353898

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Presentation] 小児IgA腎症再燃例における臨床・組織学的特徴 -マクロファージ浸潤像からみた検討-2016

    • Author(s)
      池住 洋平
    • Organizer
      第39回IgA腎症研究会
    • Place of Presentation
      JPタワー KITTE 4F ホール&カンファレンス、東京都千代田区
    • Year and Date
      2016-01-30
    • Related Report
      2015 Annual Research Report
  • [Presentation] Alternatively activated CD163+ macrophages are a common feature in progressive interstitial fibrosis.2015

    • Author(s)
      Ikezumi Y
    • Organizer
      2015 Annual Meeting of American Society of Nephrology
    • Place of Presentation
      San Diego,CA,USA
    • Year and Date
      2015-11-17
    • Related Report
      2015 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 尿細管間質線維化に関わる腎疾患特異的M2マクロファージの同定と機能解析.2015

    • Author(s)
      池住 洋平
    • Organizer
      第50回日本小児腎臓病学会学術集会
    • Place of Presentation
      神戸国際会議場、兵庫県神戸市
    • Year and Date
      2015-06-18
    • Related Report
      2015 Annual Research Report
  • [Presentation] 尿細管間質線維化に関わる腎疾患特異的M2マクロファージの機能解析.2015

    • Author(s)
      池住 洋平
    • Organizer
      第58回日本腎臓学会学術総会
    • Place of Presentation
      名古屋国際会議場、愛知県名古屋市
    • Year and Date
      2015-06-05
    • Related Report
      2015 Annual Research Report
  • [Presentation] Pro-inflammatory CD11c+CD68+ mononuclear phagocytes promote glomerular injury in lupus nephritis.2014

    • Author(s)
      Ikezumi Y
    • Organizer
      2014 Annual Meeting of American Society of Nephrology
    • Place of Presentation
      Philadelphia, Pennsylvania, USA
    • Year and Date
      2014-11-12 – 2014-11-16
    • Related Report
      2014 Research-status Report
  • [Presentation] 慢性糸球体腎炎の治療ターゲットを求めて2014

    • Author(s)
      池住洋平
    • Organizer
      第49回近畿小児腎臓病研究会
    • Place of Presentation
      大阪市
    • Year and Date
      2014-10-11
    • Related Report
      2014 Research-status Report
    • Invited
  • [Presentation] 小児ループス腎炎におけるM1、M2型マクロファージの対照的な機能の検討2014

    • Author(s)
      池住 洋平
    • Organizer
      第57回日本腎臓学会総会
    • Place of Presentation
      横浜市
    • Year and Date
      2014-07-04 – 2014-07-06
    • Related Report
      2014 Research-status Report
  • [Presentation] ターゲットを考えた小児慢性糸球体腎炎の治療:なぜIgA腎症に免疫抑制薬は効くのか2014

    • Author(s)
      池住洋平
    • Organizer
      第15回徳島県小児膠原病・腎疾患談話会
    • Place of Presentation
      徳島市
    • Year and Date
      2014-06-18
    • Related Report
      2014 Research-status Report
    • Invited
  • [Presentation] マクロファージをターゲットとした慢性糸球体腎炎の治療戦略

    • Author(s)
      池住洋平
    • Organizer
      第28回新潟腎シンポジウム
    • Place of Presentation
      新潟市
    • Related Report
      2013 Research-status Report
    • Invited
  • [Book] 小児慢性腎臓患者への予防接種2014

    • Author(s)
      池住洋平、他.日本小児感染症学会
    • Total Pages
      127
    • Publisher
      協和企画
    • Related Report
      2014 Research-status Report
  • [Book] 今日の治療指針20142014

    • Author(s)
      池住洋平
    • Total Pages
      2014
    • Publisher
      医学書院
    • Related Report
      2014 Research-status Report
  • [Book] 小児特発性ネフローゼ症候群診療ガイドライン20132013

    • Author(s)
      池住洋平,他.日本小児腎臓病学会.
    • Total Pages
      80
    • Publisher
      診断と治療社
    • Related Report
      2013 Research-status Report
  • [Book] エビデンスに基づくCKD診療ガイドライン20132013

    • Author(s)
      池住洋平,他.日本腎臓病学会
    • Total Pages
      259
    • Publisher
      東京医学社
    • Related Report
      2013 Research-status Report
  • [Book] 小児疾患の診断治療基準 第4版2013

    • Author(s)
      池住洋平
    • Total Pages
      957
    • Publisher
      東京医学社
    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi